• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

移植到猪心脏中的脂肪组织来源的分化人骨髓间充质干细胞的心脏起搏器功能

cardiac pacemaker function of differentiated human mesenchymal stem cells from adipose tissue transplanted into porcine hearts.

作者信息

Darche Fabrice F, Rivinius Rasmus, Rahm Ann-Kathrin, Köllensperger Eva, Leimer Uwe, Germann Günter, Reiss Miriam, Koenen Michael, Katus Hugo A, Thomas Dierk, Schweizer Patrick A

机构信息

Department of Cardiology, Medical University Hospital Heidelberg, Heidelberg D-69120, Germany.

Department of Plastic Surgery, ETHIANUM Klinik Heidelberg, Heidelberg D-69115, Germany.

出版信息

World J Stem Cells. 2020 Oct 26;12(10):1133-1151. doi: 10.4252/wjsc.v12.i10.1133.

DOI:10.4252/wjsc.v12.i10.1133
PMID:33178397
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7596441/
Abstract

BACKGROUND

Mesenchymal stem cells (MSC) modified by gene transfer to express cardiac pacemaker channels such as HCN2 or HCN4 were shown to elicit pacemaker function after intracardiac transplantation in experimental animal models. Human MSC derived from adipose tissue (haMSC) differentiate into cells with pacemaker properties , but little is known about their behavior after intracardiac transplantation.

AIM

To investigate whether haMSC elicit biological pacemaker function after transplantation into pig hearts.

METHODS

haMSC under native conditions (nhaMSC) or after pre-conditioning by medium differentiation (dhaMSC) ( = 6 pigs each, 5 × 10 cells/animal) were injected into the porcine left ventricular free wall. Animals receiving PBS injection served as controls ( = 6). Four weeks later, total atrioventricular (AV)-block was induced by radiofrequency catheter ablation, and electronic pacemaker devices were implanted for backup stimulation and heart rate monitoring. Ventricular rate and rhythm of pigs were evaluated during a follow-up of 15 d post ablation by 12-lead-ECG with heart rate assessment, 24-h continuous rate monitoring recorded by electronic pacemaker, assessment of escape recovery time, and pharmacological challenge to address catecholaminergic rate response. Finally, hearts were analyzed by histological and immunohistochemical investigations.

RESULTS

transplantation of dhaMSC into the left ventricular free wall of pigs elicited spontaneous and regular rhythms that were pace-mapped to ventricular injection sites (mean heart rate 72.2 ± 3.6 bpm; 6) after experimental total AV block. Ventricular rhythms were stably detected over a 15-d period and were sensitive to catecholaminergic stimulation (mean maximum heart rate 131.0 ± 6.2 bpm; 6; 0.001). Pigs, which received nhaMSC or PBS presented significantly lower ventricular rates (mean heart rates 47.2 ± 2.5 bpm and 37.4 ± 3.2 bpm, respectively; 6 each; < 0.001) and exhibited little sensitivity towards catecholaminergic stimulation (mean maximum heart rates 76.4 ± 3.1 bpm and 60.5 ± 3.1 bpm, respectively; 6 each; < 0.05). Histological and immunohistochemical evaluation of hearts treated with dhaMSC revealed local clusters of transplanted cells at the injection sites that lacked macrophage or lymphocyte infiltrations or tumor formation. Intense fluorescence signals at these sites indicated membrane expression of HCN4 and other pacemaker-specific proteins involved in cardiac automaticity and impulse propagation.

CONCLUSION

dhaMSC transplanted into pig left ventricles sustainably induced rate-responsive ventricular pacemaker activity after engraftment for four weeks. The data suggest that pre-conditioned MSC may further differentiate along a pacemaker-related lineage after myocardial integration and may establish superior pacemaker properties .

摘要

背景

在实验动物模型中,经基因转移修饰以表达心脏起搏器通道(如HCN2或HCN4)的间充质干细胞(MSC)在心脏内移植后可引发起搏器功能。源自脂肪组织的人MSC(haMSC)可分化为具有起搏器特性的细胞,但关于其心脏内移植后的行为知之甚少。

目的

研究haMSC移植到猪心脏后是否能引发生物起搏器功能。

方法

将处于天然状态的haMSC(nhaMSC)或经培养基分化预处理后的haMSC(dhaMSC)(每组6头猪,5×10⁶个细胞/只动物)注射到猪左心室游离壁。接受PBS注射的动物作为对照(每组6只)。4周后,通过射频导管消融诱导完全房室(AV)阻滞,并植入电子起搏器装置用于备用刺激和心率监测。在消融后15天的随访期间,通过12导联心电图评估猪的心室率和节律,并进行心率评估,通过电子起搏器记录24小时连续心率监测,评估逸搏恢复时间,并进行药理学激发以评估儿茶酚胺能心率反应。最后,通过组织学和免疫组织化学研究分析心脏。

结果

将dhaMSC移植到猪左心室游离壁后,在实验性完全AV阻滞诱导后引发了自发且规则的节律,这些节律通过起搏标测定位于心室注射部位(平均心率72.2±3.6次/分钟;n = 6)。在15天的时间内稳定检测到心室节律,并且对儿茶酚胺能刺激敏感(平均最大心率131.0±6.2次/分钟;n = 6;P < 0.001)。接受nhaMSC或PBS的猪心室率明显较低(平均心率分别为47.2±2.5次/分钟和37.4±3.2次/分钟;每组n = 6;P < 0.001),并且对儿茶酚胺能刺激的敏感性较低(平均最大心率分别为76.4±3.1次/分钟和60.5±3.1次/分钟;每组n = 6;P < 0.05)。对接受dhaMSC治疗的心脏进行组织学和免疫组织化学评估发现,注射部位有局部移植细胞簇,缺乏巨噬细胞或淋巴细胞浸润或肿瘤形成。这些部位强烈的荧光信号表明HCN4和其他参与心脏自律性和冲动传播的起搏器特异性蛋白的膜表达。

结论

移植到猪左心室的dhaMSC在植入4周后可持续诱导心率反应性心室起搏器活动。数据表明,预处理的MSC在心肌整合后可能沿起搏器相关谱系进一步分化,并可能建立更优越的起搏器特性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae55/7596441/e9839fc454bc/WJSC-12-1133-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae55/7596441/6e2d48eba1ae/WJSC-12-1133-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae55/7596441/7eaf1aec65f6/WJSC-12-1133-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae55/7596441/00df55d4196f/WJSC-12-1133-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae55/7596441/14c2ce8c63b3/WJSC-12-1133-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae55/7596441/dd90ae5205b7/WJSC-12-1133-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae55/7596441/00912f95f024/WJSC-12-1133-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae55/7596441/b07c436867ce/WJSC-12-1133-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae55/7596441/07fa991758b4/WJSC-12-1133-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae55/7596441/e9839fc454bc/WJSC-12-1133-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae55/7596441/6e2d48eba1ae/WJSC-12-1133-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae55/7596441/7eaf1aec65f6/WJSC-12-1133-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae55/7596441/00df55d4196f/WJSC-12-1133-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae55/7596441/14c2ce8c63b3/WJSC-12-1133-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae55/7596441/dd90ae5205b7/WJSC-12-1133-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae55/7596441/00912f95f024/WJSC-12-1133-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae55/7596441/b07c436867ce/WJSC-12-1133-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae55/7596441/07fa991758b4/WJSC-12-1133-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae55/7596441/e9839fc454bc/WJSC-12-1133-g009.jpg

相似文献

1
cardiac pacemaker function of differentiated human mesenchymal stem cells from adipose tissue transplanted into porcine hearts.移植到猪心脏中的脂肪组织来源的分化人骨髓间充质干细胞的心脏起搏器功能
World J Stem Cells. 2020 Oct 26;12(10):1133-1151. doi: 10.4252/wjsc.v12.i10.1133.
2
Pacemaker cell characteristics of differentiated and HCN4-transduced human mesenchymal stem cells.分化的和转染 HCN4 的人间质干细胞的起搏器细胞特征。
Life Sci. 2019 Sep 1;232:116620. doi: 10.1016/j.lfs.2019.116620. Epub 2019 Jul 7.
3
Functional biological pacemaker generation by T-Box18 protein expression via stem cell and viral delivery approaches in a murine model of complete heart block.通过干细胞和病毒传递方法在完全性心脏传导阻滞的小鼠模型中表达 T-Box18 蛋白生成功能性生物起搏器。
Pharmacol Res. 2019 Mar;141:443-450. doi: 10.1016/j.phrs.2019.01.034. Epub 2019 Jan 21.
4
mHCN4 genetically modified canine mesenchymal stem cells provide biological pacemaking function in complete dogs with atrioventricular block.mHCN4基因修饰的犬间充质干细胞为完全性房室传导阻滞的犬提供生物起搏功能。
Pacing Clin Electrophysiol. 2013 Sep;36(9):1138-49. doi: 10.1111/pace.12154. Epub 2013 May 10.
5
HCN4-Overexpressing Mouse Embryonic Stem Cell-Derived Cardiomyocytes Generate a New Rapid Rhythm in Rats with Bradycardia.过表达HCN4的小鼠胚胎干细胞衍生心肌细胞在心动过缓大鼠中产生新的快速心律。
Int Heart J. 2018 May 30;59(3):601-606. doi: 10.1536/ihj.17-241. Epub 2018 May 6.
6
Biological pacemaker implanted in canine left bundle branch provides ventricular escape rhythms that have physiologically acceptable rates.植入犬左束支的生物起搏器可提供具有生理可接受心率的心室逸搏心律。
Circulation. 2004 Feb 3;109(4):506-12. doi: 10.1161/01.CIR.0000114527.10764.CC. Epub 2004 Jan 20.
7
AKT-modified autologous intracoronary mesenchymal stem cells prevent remodeling and repair in swine infarcted myocardium.AKT 修饰的自体冠状动脉间充质干细胞预防猪梗死心肌的重构和修复。
Chin Med J (Engl). 2010 Jul;123(13):1702-8.
8
Bioartificial sinus node constructed via in vivo gene transfer of an engineered pacemaker HCN Channel reduces the dependence on electronic pacemaker in a sick-sinus syndrome model.通过工程化起搏器HCN通道的体内基因转移构建的生物人工窦房结可降低病态窦房结综合征模型对电子起搏器的依赖。
Circulation. 2006 Sep 5;114(10):1000-11. doi: 10.1161/CIRCULATIONAHA.106.615385. Epub 2006 Aug 21.
9
Overexpression of the medium‑conductance calcium‑activated potassium channel (SK4) and the HCN2 channel to generate a biological pacemaker.过度表达中电导钙激活钾通道 (SK4) 和 HCN2 通道以产生生物起搏器。
Mol Med Rep. 2019 Oct;20(4):3406-3414. doi: 10.3892/mmr.2019.10591. Epub 2019 Aug 20.
10
Biological pacemaker created by percutaneous gene delivery via venous catheters in a porcine model of complete heart block.经皮基因递送至静脉导管在完全性心脏阻滞猪模型中创建的生物起搏器。
Heart Rhythm. 2012 Aug;9(8):1310-8. doi: 10.1016/j.hrthm.2012.04.020. Epub 2012 Apr 20.

引用本文的文献

1
Application of adipose-derived stem cells in ischemic heart disease: theory, potency, and advantage.脂肪来源干细胞在缺血性心脏病中的应用:理论、潜能及优势。
Front Cardiovasc Med. 2024 Jan 19;11:1324447. doi: 10.3389/fcvm.2024.1324447. eCollection 2024.
2
DNA methylation cooperates with H3K9me2 at HCN4 promoter to regulate the differentiation of bone marrow mesenchymal stem cells into pacemaker-like cells.DNA 甲基化与 H3K9me2 一起作用于 HCN4 启动子,调节骨髓间充质干细胞向起搏样细胞的分化。
PLoS One. 2023 Aug 29;18(8):e0289510. doi: 10.1371/journal.pone.0289510. eCollection 2023.
3
Stem Cell Studies in Cardiovascular Biology and Medicine: A Possible Key Role of Macrophages.

本文引用的文献

1
Pacemaker cell characteristics of differentiated and HCN4-transduced human mesenchymal stem cells.分化的和转染 HCN4 的人间质干细胞的起搏器细胞特征。
Life Sci. 2019 Sep 1;232:116620. doi: 10.1016/j.lfs.2019.116620. Epub 2019 Jul 7.
2
Positive Feedback Mechanisms among Local Ca Releases, NCX, and I Ignite Pacemaker Action Potentials.局部 Ca 释放、NCX 和 I 引发起搏动作电位之间的正反馈机制。
Biophys J. 2018 Mar 13;114(5):1176-1189. doi: 10.1016/j.bpj.2017.12.043.
3
Subtype-specific differentiation of cardiac pacemaker cell clusters from human induced pluripotent stem cells.
心血管生物学与医学中的干细胞研究:巨噬细胞的潜在关键作用
Biology (Basel). 2022 Jan 12;11(1):122. doi: 10.3390/biology11010122.
从人诱导多能干细胞中特异性分化为心脏起搏细胞簇。
Stem Cell Res Ther. 2017 Oct 16;8(1):229. doi: 10.1186/s13287-017-0681-4.
4
Simultaneous engagement of mechanical stretching and surface pattern promotes cardiomyogenic differentiation of human mesenchymal stem cells.机械拉伸和表面图案的同时作用促进人间充质干细胞的心肌分化。
J Biosci Bioeng. 2017 Feb;123(2):252-258. doi: 10.1016/j.jbiosc.2016.07.020. Epub 2016 Aug 18.
5
Sinus Node and Atrial Arrhythmias.窦房结与房性心律失常
Circulation. 2016 May 10;133(19):1892-900. doi: 10.1161/CIRCULATIONAHA.116.018011.
6
Adipose-derived Mesenchymal Stem Cells and Their Reparative Potential in Ischemic Heart Disease.脂肪来源的间充质干细胞及其在缺血性心脏病中的修复潜力。
Rev Esp Cardiol (Engl Ed). 2015 Jul;68(7):599-611. doi: 10.1016/j.rec.2015.02.025. Epub 2015 May 29.
7
Biological pacemaker created by minimally invasive somatic reprogramming in pigs with complete heart block.通过微创体细胞重编程在患有完全性心脏传导阻滞的猪中创建生物起搏器。
Sci Transl Med. 2014 Jul 16;6(245):245ra94. doi: 10.1126/scitranslmed.3008681.
8
Stem cell-based biological pacemakers from proof of principle to therapy: a review.基于干细胞的生物起搏器:从原理验证到治疗的综述
Cytotherapy. 2014 Jul;16(7):873-80. doi: 10.1016/j.jcyt.2014.02.014. Epub 2014 May 13.
9
mHCN4 genetically modified canine mesenchymal stem cells provide biological pacemaking function in complete dogs with atrioventricular block.mHCN4基因修饰的犬间充质干细胞为完全性房室传导阻滞的犬提供生物起搏功能。
Pacing Clin Electrophysiol. 2013 Sep;36(9):1138-49. doi: 10.1111/pace.12154. Epub 2013 May 10.
10
Ca(2+)-stimulated adenylyl cyclase AC1 generates efficient biological pacing as single gene therapy and in combination with HCN2.钙(Ca2+)刺激的腺苷酸环化酶 AC1 作为单一基因治疗,并与 HCN2 联合使用,可产生高效的生物起搏。
Circulation. 2012 Jul 31;126(5):528-36. doi: 10.1161/CIRCULATIONAHA.111.083584. Epub 2012 Jun 29.